CIPO Patents = 5

EPO Patents = 1

Forward Citations = 2

Loading Chart...

4 inventors (with patents filed for the assignee):

Michael Vajdy (4 out of 9 patents)

Shore Padrah (3 out of 3 patents)

Shohre Golestani (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 10765735 - Adjuvant compositions and methods of use (2020-09-08),

2. 10561720 - Pharmaceutical compositions, comprising a combination of select carriers, vitamins, tannins and flavonoids as antigen-specific immuno-modulators (2020-02-18),

3. 9180184 - Adjuvant compositions and methods of use (2015-11-10),

4. 8425922 - Adjuvant compositions and methods of use (2013-04-23),

Epitogenesis, Inc. is a leading biotechnology company specializing in the development of novel immunotherapies for cancer and autoimmune diseases. Our unique approach utilizes cutting-edge technology to identify and target specific epitopes, leading to more precise and effective treatments. With a dedicated team of scientists and researchers, we are committed to improving patient outcomes and transforming the way diseases are treated.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

4 Patents

#67 in Sacramento, CA

#13,658 in California

#58,967 in US

Sacramento, CA, United States of America

Epitogenesis, Inc.

Forward Citations = 2

4 inventors:

Michael Vajdy (4 out of 9 patents)

Shore Padrah (3 out of 3 patents)

Shohre Golestani (1 out of 1 patent)

Please report any incorrect information to support@idiyas.com

5 patents (CIPO):

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com